Rare disease news

FDA approvals, research breakthroughs, clinical trials, and advocacy updates

Curated and summarized by AI for patients and caregivers

🔍
AllDrug approvalsClinical trialsResearchGrants & fundingAdvocacy & policyPipeline
Show:All newsBreaking onlyImportant & breaking
Date:7 days30 days90 daysAll time

3 articles from the last 90 days matching "Quality of Life"

Clinical trialUNITERARE2 days ago

New Recruiting Trial: Biofeedback-Assisted Pelvic Floor Rehabilitation for Radiation-Induced Sexual Dysfunction in Cervical Cancer Survivors

Researchers are testing a new treatment to help cervical cancer survivors who have sexual problems after radiation therapy. The treatment uses biofeedback—a technique that helps you learn to control your pelvic floor muscles—combined with physical rehabilitation exercises. This trial is now accepting patients to see if this approach can improve sexual function and quality of life.

WHY IT MATTERSThis trial directly addresses a common but often overlooked side effect of cervical cancer treatment, offering cervical cancer survivors a non-medication option to restore sexual function after radiation therapy.
→ You can act on thiscervical cancerradiation-induced sexual dysfunction
ResearchRSSMay 14

Vyalev eases motor, nonmotor symptoms in advanced Parkinson’s

Vyalev is a new under-the-skin pump that delivers Parkinson's disease medication continuously. In a real-world study, it reduced the amount of time patients experienced symptoms and improved both movement problems and some other symptoms like mood or sleep issues. Patients also reported better quality of life.

WHY IT MATTERSIf you have advanced Parkinson's disease and struggle with medication wearing off between doses, Vyalev offers a continuous delivery option that may reduce symptom fluctuations and improve daily functioning.
💬 Ask your doctorParkinson's disease
Clinical trialUNITERAREApr 9

New Recruiting Trial: Safety and Tolerability of Difelikefalin in Adolescents on Haemodialysis With Moderate-to-Severe Pruritus

Researchers are testing a new medicine called difelikefalin to see if it's safe and works well for teenagers on kidney dialysis who have severe itching. Itching is a common problem for dialysis patients that can really affect their quality of life. This study will check whether the medicine helps reduce itching and what side effects it might cause.

WHY IT MATTERSThis is the first trial testing difelikefalin specifically in adolescents on hemodialysis with moderate-to-severe pruritus — a condition that significantly impacts quality of life but has limited treatment options for younger patients.
→ You can act on thisChronic kidney diseaseEnd-stage renal diseaseUremic pruritus

Get personalized rare disease news

Follow your conditions to see news about the diseases that matter to you — FDA approvals, trial openings, and research breakthroughs.

Create free account →Browse diseases